Clinical significance of combined circulating TERT promoter mutations and miR-122 expression for screening HBV-related hepatocellular carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical significance of combined circulating TERT promoter mutations and miR-122 expression for screening HBV-related hepatocellular carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-18
DOI
10.1038/s41598-020-65213-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas
- (2019) David Braig et al. INTERNATIONAL JOURNAL OF CANCER
- TERTp mutation detection in plasma by droplet-digital PCR in spinal myxopapillary ependymoma with lung metastases.
- (2019) Anne Deniel et al. World Neurosurgery
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
- (2018) Kristina Tzartzeva et al. GASTROENTEROLOGY
- Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma
- (2018) Ngo Tat Trung et al. PLoS One
- Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma
- (2018) Leslie Calapre et al. Molecular Oncology
- Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
- (2016) Song He et al. Clinics and Research in Hepatology and Gastroenterology
- Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
- (2016) Jia-Cheng Tang et al. Cell and Bioscience
- Current State of Circulating MicroRNAs as Cancer Biomarkers
- (2015) Y. He et al. CLINICAL CHEMISTRY
- miR-122 is a Unique Molecule with Great Potential in Diagnosis, Prognosis of Liver Disease, and Therapy Both as miRNA Mimic and Antimir
- (2015) Sharda Thakral et al. CURRENT GENE THERAPY
- Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
- (2015) Dong-Sheng Huang et al. EUROPEAN JOURNAL OF CANCER
- A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study
- (2015) Xue-Jia Lin et al. LANCET ONCOLOGY
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations
- (2015) Dilek Cevik WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe
- (2015) Liver Cancer
- Viral-Human Chimeric Transcript Predisposes Risk to Liver Cancer Development and Progression
- (2014) Chi-Chiu Lau et al. CANCER CELL
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis
- (2014) Jean Charles Nault et al. HEPATOLOGY
- MicroRNA-122 Overexpression Promotes Hepatic Differentiation of Human Adipose Tissue-Derived Stem Cells
- (2014) Nahid Davoodian et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Circulating microRNAs as markers of liver inflammation, fibrosis and cancer
- (2014) Christoph Roderburg et al. JOURNAL OF HEPATOLOGY
- Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
- (2014) Yasushi Totoki et al. NATURE GENETICS
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma
- (2014) J. N. Honeyman et al. SCIENCE
- TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
- (2013) Marc Remke et al. ACTA NEUROPATHOLOGICA
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2012) EUROPEAN JOURNAL OF CANCER
- Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
- (2012) Wing-Kin Sung et al. NATURE GENETICS
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
- (2012) Cécile Guichard et al. NATURE GENETICS
- Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
- (2011) Jian Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
- (2011) Peng Qi et al. PLoS One
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
- (2009) Nicola Normanno et al. Nature Reviews Clinical Oncology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started